CelLBxHealth plc (AIM:CLBX)
0.8050
-0.0200 (-2.42%)
Oct 16, 2026, 3:56 PM GMT
CelLBxHealth Revenue
CelLBxHealth had revenue of 597.00K GBP in the half year ending June 30, 2026, a decrease of -42.26%. This brings the company's revenue in the last twelve months to 1.15M, down -56.10% year-over-year. In the year 2025, CelLBxHealth had annual revenue of 1.35M, down -52.80%. That makes CelLBxHealth the 42,873rd largest company in the world by revenue and 849th in the United Kingdom.
Revenue (ttm)
1.15M
Revenue Growth
-56.10%
P/S Ratio
7.89
Revenue / Employee
10.11K
Employees
114
Market Cap
9.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | -1.51M | -52.80% |
| Dec 31, 2024 | 2.86M | 676.00K | 30.92% |
| Dec 31, 2023 | 2.19M | 1.15M | 109.99% |
| Dec 31, 2022 | 1.04M | 28.00K | 2.76% |
| Dec 31, 2021 | 1.01M | 251.00K | 32.94% |
| Dec 31, 2020 | 762.00K | 181.00K | 31.15% |
| Dec 31, 2019 | 581.00K | -97.00K | -14.31% |
| Apr 30, 2019 | 678.00K | 50.00K | 7.96% |
| Apr 30, 2018 | 628.00K | 130.00K | 26.10% |
| Apr 30, 2017 | 498.00K | 137.00K | 37.95% |
| Apr 30, 2016 | 361.00K | - | - |
| Apr 30, 2015 | - | - | - |
| Apr 30, 2014 | - | - | - |
| Apr 30, 2013 | 969.02K | -438.05K | -31.13% |
| Apr 30, 2012 | 1.41M | -1.01M | -41.85% |
| Apr 30, 2011 | 2.42M | -34.61K | -1.41% |
| Apr 30, 2010 | 2.45M | -2.61M | -51.54% |
| Apr 30, 2009 | 5.06M | 1.19M | 30.75% |
| Apr 30, 2008 | 3.87M | 496.12K | 14.69% |
| Apr 30, 2007 | 3.38M | -715.51K | -17.48% |
| Apr 30, 2006 | 4.09M | -39.28K | -0.95% |
| Apr 30, 2005 | 4.13M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Palatin Technologies | 9.94M |
| Verici Dx | 2.65M |
| Fusion Antibodies | 2.11M |
| Aptamer Group | 1.54M |
CelLBxHealth News
- 3 months ago - CelLBxHealth Quarterly report: H1 2026 - Filings
- 3 months ago - CelLBxHealth Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - CelLBxHealth Annual report: H2 2025 - Filings
- 3 months ago - CelLBxHealth Annual report: H2 2025 - Filings
- 3 months ago - CelLBxHealth Slides: H2 2025 - Filings
- 5 months ago - CelLBxHealth Earnings release: Q1 2026 - Filings
- 9 months ago - CelLBxHealth Earnings release: Q4 2025 - Filings
- 9 months ago - CelLBxHealth Slides: Q4 2025 - Filings